Cue Health (HLTH) analysis compared to its peers


Cue Health (NASDAQ: HLTH – Get Rating) is one of 42 public companies in the “Analytical Instruments” sector, but how does it differ from its rivals? We will compare Cue Health to similar companies based on its dividend strength, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Valuation and benefits

This table compares the revenue, earnings per share (EPS), and valuation of Cue Health and its rivals.

Gross revenue Net revenue Price/earnings ratio
Benchmark Health $618.11 million $86.42 million -15.13
Cue Health Competitors $1.16 billion $344.59 million -139.77

Cue Health’s competitors have higher revenues and profits than Cue Health. Cue Health trades at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares the net margins, return on equity and return on assets of Cue Health and its competitors.

Net margins Return on equity return on assets
Benchmark Health -6.24% 5.50% 3.99%
Cue Health Competitors -213.16% 8.18% -12.11%

Analyst Recommendations

This is a summary of recent valuations and price targets for Cue Health and its rivals, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Benchmark Health 0 1 0 0 2.00
Cue Health Competitors 162 1007 1663 52 2.56

Cue Health currently has a consensus target price of $8.00, indicating a potential upside of 76.21%. As a group, the “Analytical Instruments” companies have an upside potential of 11.79%. Given Cue Health’s likely higher upside, stock analysts clearly believe Cue Health is more favorable than its rivals.

Insider and Institutional Ownership

26.4% of Cue Health shares are held by institutional investors. By comparison, 59.4% of the shares of all Analytical Instruments companies are held by institutional investors. 7.0% of Cue Health shares are held by insiders of the company. By comparison, 14.5% of the shares of all Analytical Instruments companies are held by insiders of the company. Strong institutional ownership indicates that endowments, hedge funds, and large fund managers believe a stock will outperform the market over the long term.

Summary

Cue Health’s rivals beat Cue Health on 8 of the 12 factors compared.

Cue Health Company Profile

(Get an assessment)

Cue Health Inc., a health technology company, designs and develops a diagnostic platform for diagnostic testing for individuals, businesses, healthcare providers and payers, and public health agencies. The Company offers Cue Integrated Care Platform consisting of hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample picking wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capabilities; Cue virtual care delivery apps, which include the Cue Health app and the Cue Enterprise dashboard; and Cue Ecosystem Integrations and Apps, a solution that enables integrations with third-party apps and sensors. It also provides COVID-19 test kits for the Cue health monitoring system. The company was formerly known as Cue Inc. and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.



Get news and reviews for Cue Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Cue Health and related companies with MarketBeat.com’s FREE daily newsletter.


Source link

Comments are closed.